David LinetskyPoint-of-Care Marketing
Joey CohenMedication Adherence
Paul TheisenPatient Acquisition
Daniel SontupeMarket Access
Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
Frank BurrellScientific Storytelling
Brenda SnowAuthentic Patient Voice
Suma Ramadas, PhDMedical Affairs
Matt TurnerPatient Affordability
Amy GilesIncreasing Engagement
Matthew DurhamOmnidynamic Marketing
Liz KaneImpactful Strategy
Stacey GandlerBrand Nourishment
YELIVA®, a proprietary, first-in-class SK2 inhibitor, was granted FDA Orphan Drug designation for the ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email